Document is current

Any future updates will be listed below

Glucagon-Like Peptide-1 Receptor Agonist Therapy Does Not Increase Gastrointestinal Adverse Events in Patients with Inflammatory Bowel Disease

Crossref DOI link: https://doi.org/10.1007/s10620-025-09344-w

Published Online: 2025-08-19

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark